Cholesterol itself isn’t bad. Your body needs it to build cell membranes, produce sex hormones, and make vitamin D. Your liver and intestines manufacture about 80% of the cholesterol in your body, with only 20% coming from food. The problem starts when one specific type, LDL cholesterol, builds up in your bloodstream and begins damaging your arteries from the inside.
What LDL Actually Does to Your Arteries
LDL particles carry cholesterol through your blood. When there are too many of them, they start accumulating in the walls of your arteries, slipping beneath the thin inner lining. Once trapped there, LDL particles become chemically modified through oxidation, and this is where the real damage begins.
Oxidized LDL triggers an inflammatory response. Your immune system sends white blood cells called monocytes to the site, where they transform into macrophages and try to swallow up the modified cholesterol. But the macrophages can’t process it all. They become bloated with cholesterol and turn into what scientists call “foam cells,” which pile up inside the artery wall. This growing mass of foam cells, cholesterol, and cellular debris forms the core of what’s known as plaque. The process also activates inflammatory pathways that recruit even more immune cells, creating a cycle where the damage feeds on itself.
Over years and decades, this plaque hardens and narrows the artery. Blood flow decreases. Organs that depend on that artery start getting less oxygen than they need.
When Plaque Becomes Dangerous
Narrowed arteries are a problem, but the real danger comes when plaque ruptures. Not all plaques are equal. The most vulnerable ones have a large core of dead cells and cholesterol covered by a thin fibrous cap, less than 65 micrometers thick, packed with inflammatory cells. When that cap tears open, the contents of the plaque are exposed to flowing blood.
The body treats this like an open wound. Platelets rush to the site, change shape, and begin clumping together. The plaque itself contains high levels of a protein called tissue factor, which kicks off a rapid chain reaction of blood clotting. Within minutes, a blood clot can form large enough to partially or completely block the artery. If that artery feeds the heart, the result is a heart attack. If it feeds the brain, it’s a stroke.
This is why someone with no obvious symptoms can have a sudden cardiac event. The plaque didn’t need to block 90% of the artery to be lethal. It just needed to rupture.
The Numbers Behind the Risk
People with total cholesterol in the highest 20% of the population (averaging around 290 mg/dL) face roughly 60% higher odds of ischemic stroke compared to those in the lowest 20%. For the specific type of stroke caused by large-artery plaque buildup, the risk is even steeper: people in that top group have about three times the odds. Genetic studies that isolate the effect of LDL specifically show that each standard deviation increase in LDL cholesterol raises the risk of large-artery stroke by 28%.
HDL cholesterol, by contrast, is protective. It picks up excess cholesterol from your blood and ferries it back to the liver for disposal. People with HDL levels of at least 35 mg/dL have roughly half the risk of ischemic stroke compared to those with lower levels. For strokes specifically caused by atherosclerosis, adequate HDL cuts the risk by about 80%.
Why Standard Tests Can Miss the Problem
A standard cholesterol panel measures the amount of cholesterol carried inside LDL particles. But what actually drives plaque formation is the number of particles themselves, not just the cholesterol they carry. A newer blood test measures a protein called apolipoprotein B (apoB), which sits on the surface of every LDL particle, one per particle. This gives a direct count of how many potentially harmful particles are circulating.
About 20% of patients have a mismatch between their LDL cholesterol number and their actual particle count. This is especially common in people with high triglycerides, type 2 diabetes, or obesity. Their LDL cholesterol can look acceptable on paper while the true number of artery-damaging particles is elevated. In these cases, apoB testing reveals a higher cardiovascular risk that the standard panel missed. Unlike traditional LDL testing, apoB measurement doesn’t require fasting and stays accurate even when triglycerides are high.
Genetics Play a Larger Role Than Most People Realize
Your liver produces cholesterol based on a combination of genetic programming and dietary raw materials. If you eat 200 to 300 mg of cholesterol per day (roughly one egg yolk), your liver compensates by producing an additional 800 mg from fats, sugars, and proteins. This means that for most people, the liver’s production capacity matters more than what’s on their plate.
About 1 in 250 to 1 in 311 people carry a genetic condition called familial hypercholesterolemia (FH), which causes extremely high LDL levels from birth. Among people who already have cardiovascular disease, the prevalence jumps to 1 in 17, meaning it’s 18 times more common in that group. FH is identified through a combination of family history and elevated LDL levels, sometimes confirmed with genetic testing. If one family member is diagnosed, close relatives can be screened with a simple blood draw or genetic test.
How LDL Levels Respond to Treatment
Lifestyle changes, particularly shifting to a diet lower in saturated fat, increasing soluble fiber intake, losing excess weight, and exercising regularly, can meaningfully reduce LDL cholesterol. But for many people, particularly those with genetic predisposition or already-elevated risk, lifestyle changes alone don’t bring levels down far enough.
Statin medications lower LDL by roughly 27% to 60%, depending on the type and dose. At the lower end, moderate doses reduce LDL by about a third. High-intensity regimens can cut LDL by more than half. Clinical trials consistently show that these reductions translate into fewer heart attacks and strokes. In one large trial, adding a second cholesterol-lowering approach on top of a statin reduced the combined risk of cardiovascular death, heart attack, and stroke by 15%.
The core principle is straightforward: the lower your LDL goes and the longer it stays low, the less plaque accumulates in your arteries. This is why cholesterol management tends to be a long-term commitment rather than a short-term fix. The damage from elevated LDL builds quietly over decades, and the benefit of lowering it compounds over time in the same way.